Skip to main content

Table 1 Regensburg registry and other published trials and registries including patients treated by the MitraClip system

From: 3D vena contracta area after MitraClip© procedure: precise quantification of residual mitral regurgitation and identification of prognostic information

  Regensburg GRASP [17] TRAMI [19] MitraSWISS [18] Pilot Registry [21]a ACCESS-EU [20] EVEREST-II [1]
Year of publication   2016 2016 2014 2014 2013 2011
Participants 102 180 749 74 628 567 184
Female [%] 42.2 38.3 38.6 27 36.9 36.2 38
Age [years] 77.0 ± 5.8 71.6 ± 9.8 76 (10)b 72 ± 12 74.2 ± 9.7 73.7 ± 9.6 67.3 ± 12.8
MR grade III/IV [%] 100 93.8 100 86.1c 97.7 96
DMR [%] 28.4 18.3 27.8 38 22.8 20.6 74
FMR [%] 71.6 81.7 71.3 62 72.0 69.3 27
NYHA III/IV [%] 75.5 81.1 89 85.5 84.9 52
EuroScore II 5.1 ± 5.9 7.6 ± 6.4
LogEuroScore [%] 26.6 ± 18.0 20 (19)f 21 ± 17 20.4 ± 16.7 23.0 ± 18.3
Regurgitant orifice area [cm2] 0.40 ± 0.18 0.43 ± 0.16 0.56 ± 0.38
  1. Shown are mean and standard deviation or proportions (if not indicated otherwise)
  2. aTranscatheter Valve Treatment Sentinel Pilot Registry, bmedian (IQR), csevere (graded as mild, moderate, severe). MR mitral regurgitation, DMR degenerative mitral regurgitation, FMR functional mitral regurgitation, NYHA New York Heart Association functional classification